$47.65 -0.1 -0.3%
Last Trade - 26/01/21
| Market Cap | £1.67bn |
| Enterprise Value | £1.72bn |
| Revenue | £526.3m |
| Position in Universe | 2004th / 6627 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,672 | 509 | 566.2 | 611.6 | 652.3 | 697.6 | 710.8 | 737.9 | -16.0% | ||
| -62.7 | +15.9 | +257.8 | +57.2 | |||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Avanos Medical, Inc., formerly Halyard Health, Inc., is a medical technology company. The Company provides a portfolio of product offerings focused on surgical and interventional pain management, respiratory and digestive health. Its products include post-operative pain management solutions, minimally invasive interventional or chronic pain therapies, closed airway suction systems and enteral feeding tubes. The company’s products are sold under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, QUIKBLOC, HOMEPUMP, CORTRAK and other brand names.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | February 25, 2014 |
| Public Since | October 21, 2014 |
| No. of Shareholders: | 12,576 |
| No. of Employees: | 4,700 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | New York Stock Exchange |
| Shares in Issue | 47,833,115 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 5405 Windward Parkway, ALPHARETTA, 30004, United States |
| Web | https://avanos.com/ |
| Phone | +1 678 4259273 |
| Contact | Dave Crawford (Vice President - Treasurer and Investor Relation) |
| Auditors | Deloitte & Touche LLP |
As of 26/01/21, shares in Avanos Medical Inc are trading at $47.65, giving the company a market capitalisation of £1.67bn. This share price information is delayed by 15 minutes.
Shares in Avanos Medical Inc are currently trading at $47.65 and the price has moved by 59.55% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Avanos Medical Inc price has moved by 34.72% over the past year.
Of the analysts with advisory recommendations for Avanos Medical Inc, there are there are currently 1 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Avanos Medical Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Avanos Medical Inc is scheduled to issue upcoming financial results on the following dates:
Avanos Medical Inc does not currently pay a dividend.
Avanos Medical Inc does not currently pay a dividend.
Avanos Medical Inc does not currently pay a dividend.
To buy shares in Avanos Medical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Avanos Medical Inc are currently trading at $47.65, giving the company a market capitalisation of £1.67bn.
Here are the trading details for Avanos Medical Inc:
Based on an overall assessment of its quality, value and momentum, Avanos Medical Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Avanos Medical Inc are currently priced at $47.65. At that level they are trading at 8.73% premium to the analyst consensus target price of 0.00.
Analysts covering Avanos Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.698 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avanos Medical Inc. Over the past six months, the relative strength of its shares against the market has been 23.49%. At the current price of $47.65, shares in Avanos Medical Inc are trading at 34.63% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Avanos Medical Inc PE ratio based on its reported earnings over the past 12 months is 73.79. The shares are currently trading at $47.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Avanos Medical Inc's management team is headed by:
Here are the top five shareholders of Avanos Medical Inc based on the size of their shareholding:
